NBQX is a potent, selective and competitive AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor antagonist. It targets both AMPA- and kainate-sensitive glutamate receptors (IC50 = 0.15 and 4.8 μM, respectively). NBQX does not block the NMDA-sensitive glutamate receptor (IC50 = ≥ 90 μM). MW: 380.24. Purity ≥98%
Size
5 mg
Concentration
n/a
Applications
n/a
Other Names
2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt